<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99219">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02001558</url>
  </required_header>
  <id_info>
    <org_study_id>MIC-UABWC-001</org_study_id>
    <nct_id>NCT02001558</nct_id>
  </id_info>
  <brief_title>Pressure Ulcer Healing With Microcyn</brief_title>
  <official_title>A Six Month Randomized Open-Label Trial of Pressure Ulcer Healing With Microcyn® Skin and Wound Care With Preservatives Versus Sterile Saline in Adult Spinal Cord Injury Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oculus Innovative Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test how well Microcyn™ works on Stage 3 and Stage 4
      pressure ulcers compared to sterile saline among persons with spinal cord injury.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pressure ulcer size (length, width, depth)</measure>
    <time_frame>pressure ulcer size (length, width and depth) at baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 4 weeks after baseline</measure>
    <time_frame>4 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 8 weeks after baseline</measure>
    <time_frame>8 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 12 weeks after baseline</measure>
    <time_frame>12 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 16 weeks after baseline</measure>
    <time_frame>16 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 20 weeks after baseline</measure>
    <time_frame>20 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pressure ulcer size (length, width and depth) at 24 weeks after baseline</measure>
    <time_frame>24 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured in mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer Scale for Healing (PUSH) score</measure>
    <time_frame>at baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 4 weeks after baseline</measure>
    <time_frame>4 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 8 weeks after baseline</measure>
    <time_frame>8 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 12 weeks after baseline</measure>
    <time_frame>12 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 16 weeks after baseline</measure>
    <time_frame>16 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 20 weeks after baseline</measure>
    <time_frame>20 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure Ulcer scale for Healing (PUSH) score at 24 weeks after baseline</measure>
    <time_frame>24 weeks after baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>PUSH categorizes pressure ulcer by surface area, exudate, and type of wound tissue. A comparison of total scores measured over time provides an indication of the improvement or deterioration in pressure ulcer healing. Total score ranges from 0 (healed, normal) to 17 (most severe).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pressure Ulcer</condition>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Microcyn</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterile saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Microcyn</intervention_name>
    <description>Microcyn is liberally sprayed on wound and permitted to remain on wound which will then be dressed with gauze that is moistened with Microcyn twice daily for the earlier of total wound closure or Week 24</description>
    <arm_group_label>Microcyn</arm_group_label>
    <other_name>Microcyn® Skin and Wound Care with preservatives</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sterile saline</intervention_name>
    <description>Sterile saline is liberally sprayed on wound and permitted to remain on wound which will then be dressed with gauze that is moistened with sterile saline twice daily for the earlier of total wound closure or Week 24</description>
    <arm_group_label>Sterile saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 17 years

          -  Persons with spinal cord injury

          -  Having Stage III/IV pressure ulcer(s)

          -  Able to fulfill all obligations of the study

        Exclusion Criteria:

          -  Pressure ulcers scheduled for surgical closure within 14 days

          -  Use of any immunosuppressant medications within 30 days of screening

          -  Having conditions that put the subject at significant risk

          -  Medically unstable or has a life expectancy of less than 12 months

          -  Current enrollment in an investigational drug or device study or participation in
             such a study within the last 30 days

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuying Chen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuying Chen, MD, PhD</last_name>
    <phone>205-934-3320</phone>
    <email>yychen@uab.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuying Chen, MD, PhD</last_name>
      <phone>205-934-3320</phone>
      <email>yychen@uab.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 27, 2013</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Yu-ying Chen</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Spinal cord injuries</keyword>
  <keyword>Pressure ulcer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pressure Ulcer</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
